Pyrogen testing market

Pyrogen Testing Market, By Test Type (Limulus Amoebocyte Lysate (LAL) Test, TAL Test, Monocyte Activation Test (MAT), Rabbit Pyrogen Test (RPT), and Recombinant Factor C Assay (rFC)), By Product Type (Instruments, Kits, and Reagents), By End User (Pharmaceutical and Biotech Companies, Food and Beverages Companies, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Request Free Sample

Nov 2020
CMI243
170 Pages
Excel & Pdf
Clinical Diagnostic

Summary

Pyrogen testing plays a major role in advanced healthcare, as it shows the presence of pyrogen in an organism that causes fever. Pyrogen can be found in lipopolysaccharides and lepoteichoic acid. Contaminated pyrogenic products can cause harmful effects such as fever in human body.

Pyrogen testing is used in detection of pyrogen contamination in pharmaceutical dosage forms and medical devices. Pyrogen contaminated injections post administration can cause temperature dysregulation (fever), bodyache, inflammation, shock, multiorgan failure, and other life threatening problems.

The global pyrogen testing market is estimated to be valued at US$ 979.7 million in 2020 and is expected to exhibit a CAGR of 12.4% over the forecast period (2020-2027).

Figure 1. Global Pyrogen Testing Market Share (%) in Terms of Value, By Region, 2019

Increasing product launches by market players is expected to propel the market growth over the forecast period

Various manufacturers are engaged in launching new testing technologies, which is expected to drive growth of the global pyrogen testing market. For instance, in May 2018, bioMérieux SA, a company focusing on industrial microbiological control, announced the launch of ENDOZYME II GO, an endotoxin test. The company launched ENDOZYME II GO under the range of recombinant horseshoe crab Factor C (rFC) assays, which enables endotoxin testing in pharmaceutical water grades, parenteral drugs, and other pharmaceutical products.

Pyrogen Testing Market Report Coverage

Report Coverage	Details
Base Year:	2019	Market Size in 2020:	US$ 979.7 Mn
Historical Data for:	2016 to 2019	Forecast Period:	2020 to 2027
Forecast Period 2020 to 2027 CAGR:	12.4%	2027 Value Projection:	US$ 2,220.5 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Test Type: Limulus Amoebocyte Lysate (LAL) Test, TAL Test, Monocyte Activation Test (MAT), Rabbit Pyrogen Test (RPT), Recombinant Factor C Assay (rFC). By Product Type: Instruments, Kits, Reagents. By End User: Pharmaceutical and Biotech Companies, Food and Beverages Companies, Others.
Companies covered:	Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc., Charles River Laboratories Inc., GenScript, WuXi PharmaTech (Cayman), Inc., bioMérieux, Wako Chemicals USA, Inc., Sanquin, Ellab A/S, and Pyrostar
Growth Drivers:	Increasing product launches by market players Increasing research and development of therapeutic drugs and medical devices
Restraints & Challenges:	Stringent regulations, which control the manufacture, distribution, marketing, and sales of medical devices and drugs

Increasing research & development of therapeutic drugs and medical devices is expected to drive the market growth over the forecast period

Increasing research and development of therapeutic drugs and medical devices is propelling growth of the pyrogen testing market over the forecast period. According to the United Nations Educational, Scientific and Cultural Organization (UNESCO), November 2016, an estimated US$ 1.7 trillion was spent on research and development for various medical applications, globally. Moreover, the U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER) approved around 59 novel drugs in 2018 compared to 46 approvals of new molecule entities in 2017.

Global Pyrogen Testing Market – Impact of Coronavirus (Covid-19) Pandemic

The coronavirus disease (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared coronavirus disease (COVID-19) as a pandemic on March 11, 2020.

According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, around 25 million cases and 800,000 deaths due to coronavirus disease (COVID-19) were reported on August 31, 2020 across the globe.

According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the coronavirus disease (COVID-19) cases in different regions reported on August 30, 2020 are as follows:

WHO Regions	New cases in last 7 days	Cumulative cases
The Americas	854,959	13,138,912
South-east Asia	539,341	4,073,148
Europe	220,777	4,205,708
Africa	44,134	1,044,513
Eastern Mediterranean	87,340	1,903,547
Western Pacific	36,260	487,571

Such dynamic increase in number of COVID-19 cases across the world has encouraged biotechnology and pharmaceutical companies to develop advanced detection kits and drugs for COVID-19, which is expected to propel growth of the pyrogen testing market over the forecast period.

Pyrogen Testing Market: Restraints

Stringent government regulations, which control the manufacture, distribution, marketing, and sales of medical devices and drugs is expected to hinder growth of the global pyrogen testing market during the forecast period.

Key Players

Major players operating in the global pyrogen testing market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc., Charles River Laboratories Inc., GenScript, WuXi PharmaTech (Cayman), Inc., bioMérieux, Wako Chemicals USA, Inc., Sanquin, Ellab A/S, and Pyrostar.

Table of Content

*Browse 23 market data tables and 26 figures on "Pyrogen Testing Market” - Global forecast to 2027

N/A

- Frequently Asked Questions -

What are the growth estimates for the global pyrogen testing market till 2027?

The global pyrogen testing market size is estimated to surpass US$ 2,220.5 million by 2027.

What will be the compound annual growth rate (CAGR) for the global pyrogen testing market during the forecast period?

The global pyrogen testing market is expected to register a CAGR of 12.4% during the forecast period (2020-2027).

What are the major drivers for the global pyrogen testing market?

The increasing product launches and increasing research and development of therapeutic drugs and medical devices are driving the global pyrogen testing market growth.

Which segment, based on test type, is estimated to account for the largest market share in the global pyrogen testing market in 2020?

The limulus amoebocyte lysate test segment is estimated to hold major market share in 2020, owing to owing to its reliability and reproducibility in detection.

What are the key factors hampering growth of the market?

Major factor hampering growth of the market is stringent regulations, which control the manufacture, distribution, marketing, and sales of medical devices and drugs.

Pyrogen testing market

Pyrogen Testing Market Report Coverage

Table of Contents

- Frequently Asked Questions -

What are the growth estimates for the global pyrogen testing market till 2027?

What will be the compound annual growth rate (CAGR) for the global pyrogen testing market during the forecast period?

What are the major drivers for the global pyrogen testing market?

Which segment, based on test type, is estimated to account for the largest market share in the global pyrogen testing market in 2020?

What are the key factors hampering growth of the market?

Which are the major players operating in the market?

Reliability and reputation

Secure Payments By: